VanEck Pharmaceutical ETF
58 hedge funds and large institutions have $141M invested in VanEck Pharmaceutical ETF in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 23 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
43% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 23
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Holders
58
Holding in Top 10
–
Calls
–
Puts
$2K
Top Buyers
| 1 | +$3.77M | |
| 2 | +$2.07M | |
| 3 | +$1.83M | |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$1.25M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.19M |
Top Sellers
| 1 | -$12.6M | |
| 2 | -$8.37M | |
| 3 | -$4.35M | |
| 4 |
LPL Financial
San Diego,
California
|
-$885K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
-$709K |